申请人:THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
公开号:US20210163440A1
公开(公告)日:2021-06-03
The present application provides pyridine, pyrimidine, and pyrazine derivatives that activate excitatory amino acid transporter 2 (EAAT2), and methods of using the derivatives for treating or preventing diseases, disorders, and conditions associated with glutamate excitotoxicity.